Our website uses cookies to make navigation as functional as possible and to perform statistics on its usage. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here. By continuing to browse this website, you will be accepting our cookies.
The Menarini Group announces meropenem/vaborbactam European marketing authorization
Meropenem/vaborbactam approved on 20th November 2018 by the European Commission for clinical use in adult patients with difficult-to-treat infections. The first combination of a carbapenem and a beta-lactamase inhibitor...
Menarini a Pomezia con “la giornata dei talenti”
Content available only in italian language
Menarini hires their 17,000th employee
The  17,000 th  employee in Menarini is Lara, 28 years old, a young graduate in Chemistry and Pharmaceutical Technology from the University of Florence, who is now employed in  Menarini Ricerche.
Page 5 of 6First   Previous   1  2  3  4  [5]  6  Next   Last